| EDG6 |
EDG6: Sphingosine 1-phosphate receptor Edg-6 |
PF4V1 |
PF4V1, SCYB4V1: Platelet factor 4 variant precursor |
0.35 |
Evidence |
|
| EDG5 |
EDG5: Sphingosine 1-phosphate receptor Edg-5 |
CXCL9 |
CXCL9, CMK, MIG, SCYB9: Small-inducible cytokine B9 precursor |
0.35 |
Evidence |
|
| OR7C1 |
OR7C1, OR7C4: Olfactory receptor 7C1 |
CCL27 |
CCL27, ILC, SCYA27: Small-inducible cytokine A27 precursor |
0.35 |
Evidence |
|
| NCK2 |
NCK2: Cytoplasmic protein NCK2 |
RYK |
RYK, JTK5A: Tyrosine-protein kinase RYK precursor |
0.35 |
Evidence |
|
| RIPK2 |
RIPK2, CARDIAK, UNQ277/PRO314/PRO34092, RICK, RIP2: Receptor-interacting serine/ |
IFIH1 |
IFIH1, MDA5, RH116: Interferon-induced helicase C domain-containing protein 1 |
0.35 |
Evidence |
|
| RIPK2 |
RIPK2, CARDIAK, UNQ277/PRO314/PRO34092, RICK, RIP2: Receptor-interacting serine/ |
MNDA |
MNDA: Myeloid cell nuclear differentiation antigen |
0.35 |
Evidence |
|
| MLNR |
MLNR, GPR38, MTLR, MTLR1: Motilin receptor |
CXCL10 |
CXCL10, INP10, SCYB10: Small-inducible cytokine B10 precursor |
0.35 |
Evidence |
|
| RGS5 |
RGS5: Regulator of G-protein signaling 5 |
GNA11 |
GNA11, GA11: Guanine nucleotide-binding protein subunit alpha-11 |
0.35 |
Evidence |
|
| SOCS1 |
SOCS1, SSI1, TIP3: Suppressor of cytokine signaling 1 |
AMHR2 |
AMHR2, AMHR: Anti-Muellerian hormone type-2 receptor precursor |
0.35 |
Evidence |
|
| CFLAR |
CFLAR, CASH, CASP8AP1, CLARP, MRIT: CASP8 and FADD-like apoptosis regulator prec |
IRAK3 |
IRAK3: Interleukin-1 receptor-associated kinase 3 |
0.35 |
Evidence |
|
| CFLAR |
CFLAR, CASH, CASP8AP1, CLARP, MRIT: CASP8 and FADD-like apoptosis regulator prec |
IFIH1 |
IFIH1, MDA5, RH116: Interferon-induced helicase C domain-containing protein 1 |
0.35 |
Evidence |
|
| CCL16 |
CCL16, ILINCK, NCC4, SCYA16: Small-inducible cytokine A16 precursor |
RXFP3 |
RXFP3, RLN3R1, SALPR: Relaxin-3 receptor 1 |
0.35 |
Evidence |
|
| CCL16 |
CCL16, ILINCK, NCC4, SCYA16: Small-inducible cytokine A16 precursor |
NPY5R |
NPY5R, NPYR5: Neuropeptide Y receptor type 5 |
0.35 |
Evidence |
|
| CCL16 |
CCL16, ILINCK, NCC4, SCYA16: Small-inducible cytokine A16 precursor |
CCR4 |
CCR4, CMKBR4: C-C chemokine receptor type 4 |
0.35 |
Evidence |
|
| CCL16 |
CCL16, ILINCK, NCC4, SCYA16: Small-inducible cytokine A16 precursor |
P2RY4 |
P2RY4, NRU: P2Y purinoceptor 4 |
0.35 |
Evidence |
|
| CCL16 |
CCL16, ILINCK, NCC4, SCYA16: Small-inducible cytokine A16 precursor |
NPY2R |
NPY2R: Neuropeptide Y receptor type 2 |
0.35 |
Evidence |
|
| CCL16 |
CCL16, ILINCK, NCC4, SCYA16: Small-inducible cytokine A16 precursor |
GPR12 |
GPR12: Probable G-protein coupled receptor 12 |
0.35 |
Evidence |
|
| CCL16 |
CCL16, ILINCK, NCC4, SCYA16: Small-inducible cytokine A16 precursor |
HRH1 |
HRH1: Histamine H1 receptor |
0.35 |
Evidence |
|
| CCL16 |
CCL16, ILINCK, NCC4, SCYA16: Small-inducible cytokine A16 precursor |
OR1D2 |
OR1D2, OLFR1: Olfactory receptor 1D2 |
0.35 |
Evidence |
|
| CCL16 |
CCL16, ILINCK, NCC4, SCYA16: Small-inducible cytokine A16 precursor |
CNR2 |
CNR2: Cannabinoid receptor 2 |
0.35 |
Evidence |
|
| CCL16 |
CCL16, ILINCK, NCC4, SCYA16: Small-inducible cytokine A16 precursor |
DRD5 |
DRD5, DRD1B, DRD1L2: D(1B) dopamine receptor |
0.35 |
Evidence |
|
| CCL16 |
CCL16, ILINCK, NCC4, SCYA16: Small-inducible cytokine A16 precursor |
CHRM5 |
CHRM5: Muscarinic acetylcholine receptor M5 |
0.35 |
Evidence |
|
| CCL16 |
CCL16, ILINCK, NCC4, SCYA16: Small-inducible cytokine A16 precursor |
HTR1A |
HTR1A, ADRB2RL1, ADRBRL1: 5-hydroxytryptamine receptor 1A |
0.35 |
Evidence |
|
| CCL16 |
CCL16, ILINCK, NCC4, SCYA16: Small-inducible cytokine A16 precursor |
OR10H3 |
OR10H3: Olfactory receptor 10H3 |
0.35 |
Evidence |
|
| ADMR |
ADMR: Adrenomedullin receptor |
CXCL9 |
CXCL9, CMK, MIG, SCYB9: Small-inducible cytokine B9 precursor |
0.35 |
Evidence |
|